Platelet disorders: an overview.

Blood Coagul Fibrinolysis

Center for Post Graduate Studies, Jain University, Jayanagar, Bangalore, India.

Published: July 2015

Thrombocytes or platelets are anucleated cells derived from megakaryocytes by process of megakaryopoiesis, with maturation time of 4-5 days. They are small and discoid in shape with size ranging from 2 to 4 μm. The platelet concentration in blood varies between 150, 000 and 400, 000  cells/μl of blood. They are involved in both hemostasis and wound healing. Hence, any abnormalities in platelets can lead to various bleeding disorders. Platelet disorders include thrombocythemia and thrombocytosis, thrombocytopenia and platelet dysfunction. Thrombocythemia and thrombocytosis are associated with increased platelet count because of overproduction of platelets. Thrombocytopenia includes decreased platelet count because of failed platelet production, increased sequestration of platelets in spleen, dilution of platelets and combination of these mechanisms. Platelet dysfunction can be because of intrinsic platelet defect or an extrinsic factor that alters the normal platelet function and can be hereditary or acquired. The following review provides a comprehensive overview of the above platelet disorders.

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mbc.0000469521.23628.2dDOI Listing

Publication Analysis

Top Keywords

platelet disorders
12
platelet
11
thrombocythemia thrombocytosis
8
platelet dysfunction
8
platelet count
8
platelets
5
disorders overview
4
overview thrombocytes
4
thrombocytes platelets
4
platelets anucleated
4

Similar Publications

Human platelet lysate: a potential therapeutic for intracerebral hemorrhage.

Front Neurosci

January 2025

Department of Neurosurgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

Intracerebral hemorrhage (ICH) is a major public health challenge worldwide, and is associated with elevated rates of mortality, disability, and morbidity, especially in low- and middle-income nations. However, our knowledge of the detailed molecular processes involved in ICH remains insufficient, particularly those involved in the secondary injury stage, resulting in a lack of effective treatments for ICH. Human platelet lysates (HPL) are abundant in bioactive factors, and numerous studies have demonstrated their beneficial effects on neurological diseases, including their anti-neuroinflammatory ability, anti-oxidant effects, maintenance of blood-brain barrier integrity, and promotion of neurogenesis.

View Article and Find Full Text PDF

Atypical hemolytic uremic syndrome (aHUS) is an important differential diagnosis in thrombotic microangiopathy (TMA). The absence of definitive biomarkers usually allows for aHUS to be diagnosed only through a process of exclusion. Due to the unfavorable prognosis if adequate therapy is delayed or not provided, differential diagnostic considerations and initiation of treatment must occur promptly.

View Article and Find Full Text PDF

Anaemia and thrombocytopenia are blood-related irregularities linked to an increased likelihood of disease progression, leading to death in people living with human immunodeficiency virus 1 (PLHIV). Severe clinical conditions associated with human immunodeficiency 1 (HIV-1) infection may be related to blood irregularities among PLHIV. The study aimed to examine the factors correlated with blood irregularities among PLHIV receiving antiretroviral treatment in West Papua.

View Article and Find Full Text PDF

Introduction: Elbow ailments are common, but conventional treatment modalities have shortcomings, offering only interim pain relief rather than targeting the underlying pathophysiology. The last two decades have seen a marked increase in the use of autologous peripheral blood-derived orthobiologics (APBOs), such as platelet-rich plasma (PRP), to manage elbow disorders. Platelet-rich plasma (PRP) is the most widely used APBO, but its efficacy remains debatable.

View Article and Find Full Text PDF

Background: High-grade serous ovarian cancer (HGSOC) remains one of the most challenging gynecological malignancies, with over 70% of ovarian cancer patients ultimately experiencing disease progression. The current prognostic tools for progression-free survival (PFS) in HGSOC patients have limitations. This study aims to develop an explainable machine learning (ML) model for predicting PFS in HGSOC patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!